Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Hagel

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
MMW Fortschritte Der Medizin|May 15, 2025
Stefan Hagel
Deutsche Medizinische Wochenschrift (1946)|October 22, 2015
[WHO-5-campaign is successful]Stefan Hagel
Viszeralmedizin|November 5, 2015
Perioperative Antibiotic Prophylaxis and Antimicrobial Therapy of Intra-Abdominal InfectionsStefan Hagel, Hubert Scheuerlein
Best Practice & Research. Clinical Gastroenterology|March 16, 2010
Adverse effects of biologics used for treating IBDAndreas Stallmach, Stefan Hagel, Tony Bruns
Intensive Care Medicine|March 23, 2022
Another trial for the TARGET trial. Author's replyStefan Hagel, Mathias W Pletz, Thomas Lehmann
MMW Fortschritte Der Medizin|November 9, 2018
[Management of community acquired pneumonia]Stefan Hagel, Anne Moeser, Mathias W Pletz
Intensive Care Medicine|March 16, 2022
Concerns about study design and suggestion of additional analysis of therapeutic drug monitoring-guided piperacillin/tazobactam therapy for patients with sepsis. Author's replyStefan Hagel, Mathias W Pletz, Thomas Lehmann
The Lancet. Infectious Diseases|April 27, 2017
Who benefits from antimicrobial combination therapy?Mathias W Pletz, Stefan Hagel, Christina Forstner
The Lancet. Infectious Diseases|January 22, 2022
In-hospital mortality of patients with severe bloodstream infection: only the tip of the icebergMathias W Pletz, Stefan Hagel, Sebastian Weis
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|April 27, 2026
[Comparison of the 2026 surviving sepsis campaign guideline and the 2025 German S3 sepsis guideline]Mathias W Pletz, Stefan Hagel, Frank M Brunkhorst
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
MMW Fortschritte Der Medizin|May 15, 2025
Stefan Hagel
Deutsche Medizinische Wochenschrift (1946)|October 22, 2015
[WHO-5-campaign is successful]Stefan Hagel
Viszeralmedizin|November 5, 2015
Perioperative Antibiotic Prophylaxis and Antimicrobial Therapy of Intra-Abdominal InfectionsStefan Hagel, Hubert Scheuerlein
Best Practice & Research. Clinical Gastroenterology|March 16, 2010
Adverse effects of biologics used for treating IBDAndreas Stallmach, Stefan Hagel, Tony Bruns
Intensive Care Medicine|March 23, 2022
Another trial for the TARGET trial. Author's replyStefan Hagel, Mathias W Pletz, Thomas Lehmann
MMW Fortschritte Der Medizin|November 9, 2018
[Management of community acquired pneumonia]Stefan Hagel, Anne Moeser, Mathias W Pletz
Intensive Care Medicine|March 16, 2022
Concerns about study design and suggestion of additional analysis of therapeutic drug monitoring-guided piperacillin/tazobactam therapy for patients with sepsis. Author's replyStefan Hagel, Mathias W Pletz, Thomas Lehmann
The Lancet. Infectious Diseases|April 27, 2017
Who benefits from antimicrobial combination therapy?Mathias W Pletz, Stefan Hagel, Christina Forstner
The Lancet. Infectious Diseases|January 22, 2022
In-hospital mortality of patients with severe bloodstream infection: only the tip of the icebergMathias W Pletz, Stefan Hagel, Sebastian Weis
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|April 27, 2026
[Comparison of the 2026 surviving sepsis campaign guideline and the 2025 German S3 sepsis guideline]Mathias W Pletz, Stefan Hagel, Frank M Brunkhorst
Pageof 14